Janet V. Johnson

727 total citations
7 papers, 502 citations indexed

About

Janet V. Johnson is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Complementary and alternative medicine. According to data from OpenAlex, Janet V. Johnson has authored 7 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Physiology and 2 papers in Complementary and alternative medicine. Recurrent topics in Janet V. Johnson's work include Heart Failure Treatment and Management (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Janet V. Johnson is often cited by papers focused on Heart Failure Treatment and Management (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Janet V. Johnson collaborates with scholars based in United States and Israel. Janet V. Johnson's co-authors include Uri Elkayam, Anilkumar Mehra, Avraham Shotan, Enrique Ostrzega, Harinder Gogia, Linda S. Chan, Robert B. Francis, Robert A. Larsen, Tao Sun and D Powars and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Clinical Infectious Diseases.

In The Last Decade

Janet V. Johnson

7 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janet V. Johnson United States 7 347 98 97 89 44 7 502
Hülya Kaşıkçıoğlu Türkiye 15 252 0.7× 52 0.5× 85 0.9× 77 0.9× 12 0.3× 33 408
Morteza Amidi United States 9 259 0.7× 92 0.9× 158 1.6× 30 0.3× 28 0.6× 22 496
Catherine Y. Campbell United States 10 169 0.5× 92 0.9× 89 0.9× 23 0.3× 14 0.3× 17 365
J. Bahlmann Germany 13 152 0.4× 88 0.9× 90 0.9× 29 0.3× 41 0.9× 56 469
Siu‐Hin Wan United States 9 400 1.2× 61 0.6× 42 0.4× 31 0.3× 13 0.3× 35 487
J Weber-Eibel Austria 5 185 0.5× 64 0.7× 86 0.9× 201 2.3× 30 0.7× 8 556
Alain Grentzinger France 12 400 1.2× 118 1.2× 179 1.8× 22 0.2× 8 0.2× 32 655
Chitose Ishikawa Japan 7 350 1.0× 149 1.5× 63 0.6× 61 0.7× 5 0.1× 17 479
Aharon Erez Israel 13 313 0.9× 89 0.9× 148 1.5× 27 0.3× 6 0.1× 23 493
H.-H. Osterhues Germany 9 134 0.4× 150 1.5× 56 0.6× 41 0.5× 16 0.4× 25 366

Countries citing papers authored by Janet V. Johnson

Since Specialization
Citations

This map shows the geographic impact of Janet V. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet V. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet V. Johnson more than expected).

Fields of papers citing papers by Janet V. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet V. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet V. Johnson. The network helps show where Janet V. Johnson may publish in the future.

Co-authorship network of co-authors of Janet V. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Janet V. Johnson. A scholar is included among the top collaborators of Janet V. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet V. Johnson. Janet V. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Elkayam, Uri, Janet V. Johnson, Avraham Shotan, et al.. (1999). Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Organic Nitrates in Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibition. Circulation. 99(20). 2652–2657. 50 indexed citations
2.
Shotan, Avraham, Enrique Ostrzega, Anilkumar Mehra, Janet V. Johnson, & Uri Elkayam. (1997). Incidence of Arrhythmias in Normal Pregnancy and Relation to Palpitations, Dizziness, and Syncope. The American Journal of Cardiology. 79(8). 1061–1064. 158 indexed citations
3.
Elkayam, Uri, Gregory H. Cohen, Harinder Gogia, et al.. (1996). Renal vasodilatory effect of endothelial stimulation in patients with chronic congestive heart failure. Journal of the American College of Cardiology. 28(1). 176–182. 28 indexed citations
4.
Gogia, Harinder, et al.. (1995). Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. Journal of the American College of Cardiology. 26(7). 1575–1580. 93 indexed citations
5.
Powars, D, Robert A. Larsen, Janet V. Johnson, et al.. (1993). Epidemic Meningococcemia and Purpura Fulminans with Induced Protein C Deficiency. Clinical Infectious Diseases. 17(2). 254–261. 121 indexed citations
6.
Shotan, Avraham, Anil Mehra, Enrique Ostrzega, et al.. (1993). Plasma cyclic guanosine monophosphate in chronic heart failure: Hemodynamic and neurohormonal correlations and response to nitrate therapy. Clinical Pharmacology & Therapeutics. 54(6). 638–644. 11 indexed citations
7.
Mehra, Anil, Enrique Ostrzega, Avraham Shotan, Janet V. Johnson, & Uri Elkayam. (1992). Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril. The American Journal of Cardiology. 70(15). 1310–1314. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026